Cargando…
Omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis
BACKGROUND: Osteochondrosis (OC(D)) is a juvenile osteo-articular disorder affecting several mammalian species. In horses, OC(D) is considered as a multifactorial disease and has been described as a focal disruption of endochondral ossification leading to the development of osteoarticular lesions. N...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233069/ https://www.ncbi.nlm.nih.gov/pubmed/25359417 http://dx.doi.org/10.1186/1471-2164-15-947 |
_version_ | 1782344682414538752 |
---|---|
author | Desjardin, Clémence Riviere, Julie Vaiman, Anne Morgenthaler, Caroline Diribarne, Mathieu Zivy, Michel Robert, Céline Le Moyec, Laurence Wimel, Laurence Lepage, Olivier Jacques, Claire Cribiu, Edmond Schibler, Laurent |
author_facet | Desjardin, Clémence Riviere, Julie Vaiman, Anne Morgenthaler, Caroline Diribarne, Mathieu Zivy, Michel Robert, Céline Le Moyec, Laurence Wimel, Laurence Lepage, Olivier Jacques, Claire Cribiu, Edmond Schibler, Laurent |
author_sort | Desjardin, Clémence |
collection | PubMed |
description | BACKGROUND: Osteochondrosis (OC(D)) is a juvenile osteo-articular disorder affecting several mammalian species. In horses, OC(D) is considered as a multifactorial disease and has been described as a focal disruption of endochondral ossification leading to the development of osteoarticular lesions. Nevertheless, OC(D) physiopathology is poorly understood. Affected horses may present joint swelling, stiffness and lameness. Thus, OC(D) is a major concern for the equine industry. Our study was designed as an integrative approach using omics technologies for the identification of constitutive defects in epiphyseal cartilage and/or subchondral bone associated with the development of primary lesions to further understand OC(D) pathology. This study compared samples from non-affected joints (hence lesion-free) from OC(D)-affected foals (n = 5, considered predisposed samples) with samples from OC-free foals (n = 5) considered as control samples. Consequently, results are not confounded by changes associated with the evolution of the lesion, but focus on altered constitutive molecular mechanisms. Comparative proteomics and micro computed tomography analyses were performed on predisposed and OC-free bone and cartilage samples. Metabolomics was also performed on synovial fluid from OC-free, OC(D)-affected and predisposed joints. RESULTS: Two lesion subtypes were identified: OCD (lesion with fragment) and OC (osteochondral defects). Modulated proteins were identified using omics technologies (2-DE proteomics) in cartilage and bone from affected foals compare to OC-free foals. These were associated with cellular processes including cell cycle, energy production, cell signaling and adhesion as well as tissue-specific processes such as chondrocyte maturation, extracellular matrix and mineral metabolism. Of these, five had already been identified in synovial fluid of OC-affected foals: ACTG1 (actin, gamma 1), albumin, haptoglobin, FBG (fibrinogen beta chain) and C4BPA (complement component 4 binding protein, alpha). CONCLUSION: This study suggests that OCD lesions may result from a cartilage defect whereas OC lesions may be triggered by both bone and cartilage defects, suggesting that different molecular mechanisms responsible for the equine osteochondrosis lesion subtypes and predisposition could be due to a defect in both bone and cartilage. This study will contribute to refining the definition of OC(D) lesions and may improve diagnosis and development of therapies for horses and other species, including humans. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2164-15-947) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4233069 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42330692014-11-17 Omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis Desjardin, Clémence Riviere, Julie Vaiman, Anne Morgenthaler, Caroline Diribarne, Mathieu Zivy, Michel Robert, Céline Le Moyec, Laurence Wimel, Laurence Lepage, Olivier Jacques, Claire Cribiu, Edmond Schibler, Laurent BMC Genomics Research Article BACKGROUND: Osteochondrosis (OC(D)) is a juvenile osteo-articular disorder affecting several mammalian species. In horses, OC(D) is considered as a multifactorial disease and has been described as a focal disruption of endochondral ossification leading to the development of osteoarticular lesions. Nevertheless, OC(D) physiopathology is poorly understood. Affected horses may present joint swelling, stiffness and lameness. Thus, OC(D) is a major concern for the equine industry. Our study was designed as an integrative approach using omics technologies for the identification of constitutive defects in epiphyseal cartilage and/or subchondral bone associated with the development of primary lesions to further understand OC(D) pathology. This study compared samples from non-affected joints (hence lesion-free) from OC(D)-affected foals (n = 5, considered predisposed samples) with samples from OC-free foals (n = 5) considered as control samples. Consequently, results are not confounded by changes associated with the evolution of the lesion, but focus on altered constitutive molecular mechanisms. Comparative proteomics and micro computed tomography analyses were performed on predisposed and OC-free bone and cartilage samples. Metabolomics was also performed on synovial fluid from OC-free, OC(D)-affected and predisposed joints. RESULTS: Two lesion subtypes were identified: OCD (lesion with fragment) and OC (osteochondral defects). Modulated proteins were identified using omics technologies (2-DE proteomics) in cartilage and bone from affected foals compare to OC-free foals. These were associated with cellular processes including cell cycle, energy production, cell signaling and adhesion as well as tissue-specific processes such as chondrocyte maturation, extracellular matrix and mineral metabolism. Of these, five had already been identified in synovial fluid of OC-affected foals: ACTG1 (actin, gamma 1), albumin, haptoglobin, FBG (fibrinogen beta chain) and C4BPA (complement component 4 binding protein, alpha). CONCLUSION: This study suggests that OCD lesions may result from a cartilage defect whereas OC lesions may be triggered by both bone and cartilage defects, suggesting that different molecular mechanisms responsible for the equine osteochondrosis lesion subtypes and predisposition could be due to a defect in both bone and cartilage. This study will contribute to refining the definition of OC(D) lesions and may improve diagnosis and development of therapies for horses and other species, including humans. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2164-15-947) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-31 /pmc/articles/PMC4233069/ /pubmed/25359417 http://dx.doi.org/10.1186/1471-2164-15-947 Text en © Desjardin et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Desjardin, Clémence Riviere, Julie Vaiman, Anne Morgenthaler, Caroline Diribarne, Mathieu Zivy, Michel Robert, Céline Le Moyec, Laurence Wimel, Laurence Lepage, Olivier Jacques, Claire Cribiu, Edmond Schibler, Laurent Omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis |
title | Omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis |
title_full | Omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis |
title_fullStr | Omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis |
title_full_unstemmed | Omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis |
title_short | Omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis |
title_sort | omics technologies provide new insights into the molecular physiopathology of equine osteochondrosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233069/ https://www.ncbi.nlm.nih.gov/pubmed/25359417 http://dx.doi.org/10.1186/1471-2164-15-947 |
work_keys_str_mv | AT desjardinclemence omicstechnologiesprovidenewinsightsintothemolecularphysiopathologyofequineosteochondrosis AT rivierejulie omicstechnologiesprovidenewinsightsintothemolecularphysiopathologyofequineosteochondrosis AT vaimananne omicstechnologiesprovidenewinsightsintothemolecularphysiopathologyofequineosteochondrosis AT morgenthalercaroline omicstechnologiesprovidenewinsightsintothemolecularphysiopathologyofequineosteochondrosis AT diribarnemathieu omicstechnologiesprovidenewinsightsintothemolecularphysiopathologyofequineosteochondrosis AT zivymichel omicstechnologiesprovidenewinsightsintothemolecularphysiopathologyofequineosteochondrosis AT robertceline omicstechnologiesprovidenewinsightsintothemolecularphysiopathologyofequineosteochondrosis AT lemoyeclaurence omicstechnologiesprovidenewinsightsintothemolecularphysiopathologyofequineosteochondrosis AT wimellaurence omicstechnologiesprovidenewinsightsintothemolecularphysiopathologyofequineosteochondrosis AT lepageolivier omicstechnologiesprovidenewinsightsintothemolecularphysiopathologyofequineosteochondrosis AT jacquesclaire omicstechnologiesprovidenewinsightsintothemolecularphysiopathologyofequineosteochondrosis AT cribiuedmond omicstechnologiesprovidenewinsightsintothemolecularphysiopathologyofequineosteochondrosis AT schiblerlaurent omicstechnologiesprovidenewinsightsintothemolecularphysiopathologyofequineosteochondrosis |